Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine [Phase 3]
Phase 3 clinical trial update investigates dose escalation for patients with ADHD who do not respond to standard atomoxetine doses.
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)
A completed clinical trial evaluated oral health status and the prevalence of dental trauma in children treated with methylphenidate (Ritali…
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Methylphenidate in ADHD With Trichotillomania [Phase 4]
Phase 4 clinical trial evaluating methylphenidate for ADHD with trichotillomania. The current status of the study is not reported.
-
CLINICAL_TRIALS trial_result · 2007-10-26Clinical Trial Update: Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]
This update notes the completion of a Phase 2 clinical trial evaluating an unspecified herbal treatment for Attention Deficit Hyperactivity …
-
FDA approval · 2007-09-28FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for STRATTERA (atomoxetine hydrochloride) submitted by Eli Lilly and Company. This action update…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-09-27Clinical Trial Update: Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents [Phase 4]
This clinical trial update describes a Phase 4 study examining how attention deficit hyperactivity disorder and substance use disorder influ…
-
FDA approval · 2007-08-31FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Dextroamphetamine Sulfate Extended-Release, a generic product manufactured by SpecGx LLC.
-
FDA approval · 2007-08-31FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Dextroamphetamine sulfate from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS research · 2007-06-19Clinical Trial Update: Inflammation in Children With Attention-Deficit/Hyperactivity Disorder
This clinical trial update notes a study investigating inflammation in children with Attention-Deficit/Hyperactivity Disorder. The status an…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Safety Study in Outpatient Japanese Children With ADHD [Phase 2]
This document reports the completion of a Phase 2 safety study of atomoxetine (Strattera) for ADHD in outpatient Japanese children, sponsore…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD [Phase 3]
Phase 3 clinical trial comparing atomoxetine hydrochloride with a comparator in pediatric outpatients with Attention Deficit Hyperactivity D…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Evaluation of Continuous Symptom Treatment of ADHD [Phase 4]
Phase 4 trial update evaluating continuous symptom treatment for Attention Deficit Hyperactivity Disorder. Sponsor: Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD [Phase 4]
Phase 4 clinical trial evaluating safety and efficacy of switching from stimulant medication to atomoxetine in children and adolescents with…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD [Phase 3]
Phase 3 trial comparing atomoxetine hydrochloride to placebo in Taiwanese children and adolescents with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD [Phase 4]
Phase 4 study of atomoxetine for attention deficit and hyperactive/impulsive behavior in children with autism spectrum disorder has complete…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy [Phase 3]
Phase 3 clinical trial update evaluating atomoxetine in children with ADHD who did not respond to stimulant therapy, comparing atomoxetine p…
-
CLINICAL_TRIALS trial_result · 2007-06-12Clinical Trial Update: Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder [Phase 3]
This Phase 3 trial evaluated the efficacy, tolerability, and safety of once-daily atomoxetine hydrochloride versus placebo in Russian childr…
-
CLINICAL_TRIALS trial_result · 2007-06-08Clinical Trial Update: Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder [Phase 4]
A Phase 4 placebo-controlled trial of atomoxetine hydrochloride in adults with ADHD and comorbid social anxiety disorder has completed.
-
FDA approval · 2007-06-07FDA Approved: METHYLIN — Supplemental Application (SHIONOGI INC.)
FDA approved a supplemental application for Methylin (methylphenidate hydrochloride) from Shionogi Inc. The action indicates regulatory appr…
-
FDA approval · 2007-05-22FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a combination of four amphetamine salt–forms (dextroamphetamine sacchar…
-
FDA approval · 2007-05-04FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride CD from Lannett Company, Inc., under NDA 021259.
-
FDA approval · 2007-05-03FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2007-05-01FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved a supplemental application for the Methylphenidate Transdermal System submitted by Padagis US LLC for the treatment of attentio…
-
FDA approval · 2007-05-01FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) from Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2007-04-30Clinical Trial Update: Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder [Phase 2]
Phase 2 trial evaluating the efficacy and safety of NS2359 in adults with attention-deficit/hyperactivity disorder has completed.